Abstract
A low-intervention policy for Hickman catheter maintenance has been evaluated and found to be safe and cost effective. A simple, lightweight, disposable device has been used for 24-hour ambulatory home infusion. Implementation of this policy as part of a prospective randomized trial of single-agent chemotherapy in advanced breast cancer has demonstrated that slow intravenous infusion reduces the acute toxicity of epirubicin when compared with bolus injection.
Cite
CITATION STYLE
Ebbs, S. R., Saunders, J. A., Roberts, J. V., Baum, M., Bates, T., & Morris, J. E. (1988). Simplifying infusion chemotherapy: preliminary communication. Journal of the Royal Society of Medicine, 81(1), 13–14. https://doi.org/10.1177/014107688808100107
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
